Form 8-K - Current report:
SEC Accession No. 0001558370-21-013981
Filing Date
2021-11-02
Accepted
2021-11-02 07:10:16
Documents
14
Period of Report
2021-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vygr-20211102x8k.htm   iXBRL 8-K 42068
2 EX-99.1 vygr-20211102xex99d1.htm EX-99.1 123079
3 GRAPHIC vygr-20211102xex99d1001.jpg GRAPHIC 130065
  Complete submission text file 0001558370-21-013981.txt   474294

Data Files

Seq Description Document Type Size
4 EX-101.SCH vygr-20211102.xsd EX-101.SCH 3084
5 EX-101.LAB vygr-20211102_lab.xml EX-101.LAB 15274
6 EX-101.PRE vygr-20211102_pre.xml EX-101.PRE 9849
7 EXTRACTED XBRL INSTANCE DOCUMENT vygr-20211102x8k_htm.xml XML 4663
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 211369239
SIC: 2836 Biological Products, (No Diagnostic Substances)